Correlation Between Astellas Pharma and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Astellas Pharma and Roche Holding Ltd, you can compare the effects of market volatilities on Astellas Pharma and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Roche Holding.

Diversification Opportunities for Astellas Pharma and Roche Holding

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Astellas and Roche is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Roche Holding go up and down completely randomly.

Pair Corralation between Astellas Pharma and Roche Holding

Assuming the 90 days horizon Astellas Pharma is expected to under-perform the Roche Holding. In addition to that, Astellas Pharma is 1.18 times more volatile than Roche Holding Ltd. It trades about -0.04 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about 0.03 per unit of volatility. If you would invest  3,296  in Roche Holding Ltd on August 27, 2024 and sell it today you would earn a total of  248.00  from holding Roche Holding Ltd or generate 7.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Astellas Pharma  vs.  Roche Holding Ltd

 Performance 
       Timeline  
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Roche Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Astellas Pharma and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Astellas Pharma and Roche Holding

The main advantage of trading using opposite Astellas Pharma and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind Astellas Pharma and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios